You have the following exclusive opportunity over the next five years. You can spend $500M on a new gene technology that can generate $45M in cash flows for the next ten years. The cost of capital similar gene technology firms is 12%, and the standard deviation of returns for gene companies is 60%. The risk-free rate is 3%. What is the value of this opportunity today?